Salbutamol Sulphate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 27 USDMF, 11 CEP/COS, 1 JDMF, 5 EU WC, 2 KDMF, 22 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

389 FDF Dossiers, 134 FDA Orange Book, 109 Europe, 21 Canada, 18 Australia, 42 South Africa, 65 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH, SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH, AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 8 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 11 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 11 Corel Pharma Chem, 6 DFE Pharma, 3 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 35 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 30 Direct Compression, 29 Controlled & Modified Release, 23 Thickeners and Stabilizers, 20 Granulation, 19 Film Formers & Plasticizers, 19 Disintegrants & Superdisintegrants, 18 Taste Masking, 17 Lubricants & Glidants, 15 Co-Processed Excipients, 15 Topical, 11 Parenteral, 10 Solubilizers, 8 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 88 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 92 Finished Drug Prices, 19 Annual Reports

MARKET PLACE

31 APIs, 14 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

45 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 5 USP, 23 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20950 / DOSAGE - SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ALBUTEROL SULFATE(UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E)	ALBUTEROL SULFATE	3mg in 3
IPRATROPIUM BROMIDE(UNII: J697UZ2A9J) (IPRATROPIUM - UNII:GR88G0I6UL)	IPRATROPIUM BROMIDE	0.5mg in 3

Inactive Ingredients

Ingredient Name	Eon Labs, Inc.
EDETATE DISODIUM(7FLD91C86K)
HYDROCHLORIC ACID(QTT17582CB)
SODIUM CHLORIDE(451W47IQ8X)
WATER(059QF0KO0R)

Drug Product Composition: Salbutamol Sulphate